13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 51 holding rows worth $735,220,583.
- Accession
- 0001172661-23-003013
- Filer
- CIK 1792126
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 51 entries on the cover page, a total value of $735,220,583 stated on the cover page (in dollars after the unit check, H1), rows summing to $735,220,583 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 625,000 | $56,937,500 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,650,000 | $53,823,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,250,000 | $42,682,500 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,750,000 | $41,125,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 300,000 | $34,356,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,743,875 | $33,807,191 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 500,000 | $29,980,000 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 100,000 | $28,485,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 300,000 | $28,290,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,125,000 | $26,763,750 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 520,000 | $24,278,800 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 5,250,000 | $22,890,000 | dollars as filed | |
| ICOSAVAX INC | 45114M109 | COM | 2,165,741 | $21,505,808 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,780,000 | $20,025,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,797,501 | $17,624,256 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 400,000 | $16,628,000 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 500,000 | $15,810,000 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 750,000 | $15,232,500 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 520,000 | $13,270,400 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 3,500,000 | $12,320,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 650,000 | $11,180,000 | dollars as filed | call |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 275,000 | $10,587,500 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 250,000 | $10,165,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 800,000 | $9,472,000 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 2,800,000 | $9,212,000 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 1,200,000 | $8,964,000 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 100,000 | $8,668,000 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 250,000 | $8,200,000 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 650,000 | $7,761,000 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 35,000 | $7,589,750 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,000,000 | $7,510,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,200,000 | $7,062,000 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 1,178,787 | $6,872,328 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 1,800,000 | $6,858,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 307,076 | $6,267,421 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 500,000 | $5,770,000 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 525,000 | $5,701,500 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 525,000 | $5,444,250 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 500,000 | $5,290,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 300,000 | $5,160,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 250,000 | $4,967,500 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 200,000 | $4,906,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 544,960 | $4,539,517 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 600,000 | $3,522,000 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 1,200,000 | $2,280,000 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 188,390 | $1,770,866 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 3,142,880 | $1,415,867 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 421,184 | $1,057,172 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 280,000 | $638,400 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 31,872 | $542,780 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $11,027 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-23-003013 | this filing | 2023-08-14 | acceptance time not in the bulk data set |